These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Progress in the management of ovarian cancer at the First Department of Obstetrics and Gynecology, University of Vienna, since 1955. Gitsch E; Salzer H Verh K Acad Geneeskd Belg; 1993; 55(2):145-9. PubMed ID: 8480450 [No Abstract] [Full Text] [Related]
44. [The follow up of prognostic important factors and analysis of five years survival rate in patients with uveal melanoma at the Department of Ophthalmology, 3rd Medical Faculty Charles University in Prague and the Faculty Hospital Královské Vinohrady in Prague]. Redinová MV; Sach J; Baráková D; Kuchynka P; Vránová J Cesk Slov Oftalmol; 2009 Jan; 65(1):29-35. PubMed ID: 19366035 [TBL] [Abstract][Full Text] [Related]
45. [Prognostic factors in ovarian carcinoma]. Sliutz G Wien Med Wochenschr; 1996; 146(1-2):14-7. PubMed ID: 8835490 [TBL] [Abstract][Full Text] [Related]
46. The management in ovarian cancer at the First Dept. of Obstetrics and Gynecology, University of Vienna. Gitsch E; Salzer H Eur J Gynaecol Oncol; 1992; 13(1):61-4. PubMed ID: 1547795 [TBL] [Abstract][Full Text] [Related]
47. [Prognosis factors in epithelial tumors of the ovary]. Frigerio L; Ferrari A; Busci L; Pirondini A; Garsia S; Caldarella M; Pifarotti G Ann Ostet Ginecol Med Perinat; 1989; 110(6):283-9. PubMed ID: 2639615 [TBL] [Abstract][Full Text] [Related]
48. [Vulvar carcinoma--retrospective study of 47 cases (epidemiology, etiology and long-term results]. Jancárková N; Freitag P; Zivný J Ceska Gynekol; 2002 Mar; 67(2):78-82. PubMed ID: 11987574 [TBL] [Abstract][Full Text] [Related]
49. Survivorship as an element of clinical trials in ovarian cancer. McAlpine JN; Wenzel LB; Int J Gynecol Cancer; 2011 May; 21(4):788-92. PubMed ID: 21543942 [No Abstract] [Full Text] [Related]
50. Meta-analysis of transcriptome reveals let-7b as an unfavorable prognostic biomarker and predicts molecular and clinical subclasses in high-grade serous ovarian carcinoma. Tang Z; Ow GS; Thiery JP; Ivshina AV; Kuznetsov VA Int J Cancer; 2014 Jan; 134(2):306-18. PubMed ID: 23825028 [TBL] [Abstract][Full Text] [Related]
51. [Resistance/sensitivity in vitro in ovarian cancer patients]. Sedláková I; Tosner J; Rezác A; Cervinka M; Brigulová K; Spacek J; Tomsová M; Skapinec P Ceska Gynekol; 2010 May; 75(3):182-7. PubMed ID: 20731297 [TBL] [Abstract][Full Text] [Related]
52. [-CA-125 antigen as a prognostic factor for survival in patients with epithelial ovarian carcinoma of FIGO stage I--preliminary results-]. Nagele E; Kurz C; Speiser P; Vavra N; Sevelda P Geburtshilfe Frauenheilkd; 1996 Feb; 56(2):79-82. PubMed ID: 8647363 [TBL] [Abstract][Full Text] [Related]
53. Ovarian carcinoma associated with pregnancy. A review of 9 cases. Sayedur Rahman M; Al-Sibai MH; Rahman J; Al-Suleiman SA; El-Yahia AR; Al-Mulhim AA; Al-Jama F Acta Obstet Gynecol Scand; 2002 Mar; 81(3):260-4. PubMed ID: 11966485 [TBL] [Abstract][Full Text] [Related]
54. [Granulosa cell tumor--clinical group and literature review]. Freitag P; Janousek M; Jancárková N; Bendová M; Strunová M; Zivný J Ceska Gynekol; 2000 May; 65(3):163-6. PubMed ID: 10953492 [TBL] [Abstract][Full Text] [Related]
57. [Prognostic factors of epithelial ovarian cancer in young women]. Zhang R; Wu LY; Zhang WH; Li HJ; Li SM; Liu LY Zhonghua Zhong Liu Za Zhi; 2003 May; 25(3):264-7. PubMed ID: 12839691 [TBL] [Abstract][Full Text] [Related]